[ad_1] Healthcare conglomerate CVS Health Corporation (NYSE: CVS) on Wednesday announced second-quarter 2024 results, reporting a decrease in adjusted earnings despite higher revenues. However, earnings topped expectations. June-quarter adjusted profit decreased 17% year-over-year to $1.83 per share but came in…
[ad_1] Image source: Getty Images A great thing about being a UK investor is the abundance of listed companies paying out passive income in the form of dividends. Tritax Big Box (LSE: BBOX) is one example. The FTSE 250-listed real…
[ad_1] Rockwell Automation, Inc. (NYSE: ROK), a global leader in industrial automation and digital transformation, on Wednesday reported a decline in sales and profit for the third quarter of 2024. Third quarter sales were $2.05 billion, down 8.4% from $2.24…
[ad_1] Image source: Getty Images The Bank of England (BoE) last week announced its first interest rate cut in this cycle. I believe plenty of FTSE 100 stocks could experience better fortunes ahead if this trend continues. Two stocks on…
[ad_1] Uber Technologies, Inc. (NYSE: UBER) this week reported better-than-expected revenue and earnings for the June quarter, driving the stock higher after the announcement. Ever since the company ended a prolonged losing streak and turned profitable a year ago, the…
[ad_1] Image source: Getty Images I reckon investing in dividend-paying stocks is a great way to build a second income. Let me break down how I’d approach this. Steps I’d follow A Stocks and Shares ISA is the perfect investment…
[ad_1] Shares of The Walt Disney Company (NYSE: DIS) dropped over 2% on Wednesday. The stock has dropped 17% over the past three months. The entertainment behemoth delivered third-quarter 2024 revenue and profits that beat expectations, and raised its earnings…
[ad_1] Image source: Getty Images I’m sure everyone has different ideas as to the best shares to buy for their ideal pot of holdings. For me personally, B&M European Value (LSE: BME) and National Grid (LSE: NG.) are two picks…
[ad_1] Biotechnology company Bio-Techne Corporation (NASDAQ: TECH) on Wednesday announced financial results for the fourth quarter of 2024, reporting a decline in profit. Fourth-quarter organic revenue edged up 1% to $306.1 million; net sales moved up 2% during the three…
[ad_1] Image source: Getty Images The FTSE 250 share I’m looking at today could be exactly the kind of stock I want to buy. Cheap, with lots of cash, and a very high dividend yield. Of course, it’s not quite…